News

The agency told Bayer it needs additional time to review the non-hormonal drug, called elinzanetant. Regulators in Canada and ...
The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...
At a recent U.S. Food and Drug Administration (F.D.A.) panel, doctors argued for the removal of the black box warning on ...
The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...
The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...
The contrast between the FDA’s clinical lens and the raw realities in the Bonafide study highlights a critical disconnect ...
A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...